Insiders · Profile

Manion Douglas J.

Pres and CEO at Aclaris Therapeutics. Filing since 9 Mar 2023. CIK 0001875875

Company
Date
Role
Action
Shares
Amount
Of holding
17 Mar 2023
Pres and CEO
Bought
6,300
$49.53K
96.9%
9 Mar 2023
Pres and CEO
Bought
6,500
$50.28K
opened
2 decisions on file.